ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 604

Characterisation of Mucosal-Associated Invariant T (MAIT) Cells in Ankylosing Spondylitis Patients

Ibrahim Almaghlouth1, Eric Gracey2, Zoya Qaiyum2, Robert D. Inman3 and Ammepa Anton4, 1Division of Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, 2Department of Immunology, University of Toronto, Toronto, ON, Canada, 3Department of Medicine, University of Toronto, Toronto, ON, Canada, 4Rheumatology, University Health Network, Toronto, ON, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: AS

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

 

Background/Purpose:

Ankylosing spondylitis (AS) is chronic inflammatory disease of unknown origin.  Studies into the molecular basis of AS  have demonstrated  exaggerated innate and adaptive immune responses mediated though various cytokines. Over-expression of  cytokines such as TNF–α and IL-17 – has provided  a rationale for targeted biologic agents for  suppressing the disease activity. Identifying the cellular sources of these cytokines is crucial to understand the pillars of inflammation in AS. Recently;, mucosal associated invariant T (MAIT)-cells have been implicated in various autoimmune diseases. Their effectors phenotype and preferential localization to peripheral tissue makes them possible contributor in the pathogenesis of AS . Thus we hypothesized that MAIT cells may be increased  in AS patients compared to normal controls.

Methods:

Peripheral blood mononuclear cells (PBMC) and synovial fluid (SF) mononuclear cells (SFMC) from the AS patients (N=17) and controls (n=11) were isolated, . Healthy controls were used for the MAIT cells in the in PBMC while RA and OA were used as controls for the SF  MAIT cells. Flow cytometry was used to identify MAIT cells, which were defined as CD3+CD161hiV.α 7.2+CCR6+, with the majority being CD8+.  Cytokine production by respective cell populations  was assessed indirectly  by intracellular straining  for IL-4, IL-17, TNFa , IFNg  and granzyme B.

Results:

The percentage of MAIT cells in PBMC of AS patients and control groups were similar.   Whereas CD69+ (activation marker) and CCR6+(homing marker) MAIT cells were comparable in AS and HC,  CCR6+ MAIT showed a tendency to be higher  in AS PBMC. It  was noted that in PBMC, activated MAIT cells (CD69+) represented  a small proportion of the total MAIT cells in. In contrast,  almost all SF MAIT cells from AS patients were activated (CD69+). We also noticed that the percentage of CD4+ MAIT to total MAIT cells in AS SF  is higher than peripheral blood. Similar results were seen in paired patient blood-synovial fluid analysis. In this analysis,; IL17 production was similar while an increased granzyme B production and reduction of IL4, IFNγ and TNFα were detected in SF MAIT cells compared to MAIT cells in PBMC.

Conclusion:

To our knowledge, this study is the first to look at MAIT cells in both blood and SF of AS patients.ij. Interestingly MAIT cells  in the inflamed joints in AS are predominantly  activated.  This suggests that examining the microenvironment of the joint to define the activating signals for local MAIT cells would be productive.


Disclosure:

I. Almaghlouth,
None;

E. Gracey,
None;

Z. Qaiyum,
None;

R. D. Inman,

Advisory board and grant,

5;

A. Anton,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterisation-of-mucosal-associated-invariant-t-mait-cells-in-ankylosing-spondylitis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology